Lixia Wang

microRNA‐132 inhibits cardiomyocyte apoptosis and myocardial remodeling in myocardial infarction by targeting IL‐1β

S. Du, S. Shen, Zonglei Zhao, 2020, Journal of cellular physiology.

Inhibiting MicroRNA-29a Protects Myocardial Ischemia-Reperfusion Injury by Targeting SIRT1 and Suppressing Oxidative Stress and NLRP3-Mediated Pyroptosis Pathway

Donghai Liu, Lixia Wang, S. Ding, 2019, The Journal of Pharmacology and Experimental Therapeutics.

Suppression of microRNA-323-3p restrains vascular endothelial cell apoptosis via promoting sirtuin-1 expression in coronary heart disease.

S. Du, S. Shen, Lixia Wang, 2021, Life sciences.

LincRNA DYN‐LRB2‐2 upregulates cholesterol efflux by decreasing TLR2 expression in macrophages

S. Shen, Yongqiang Li, Lixia Wang, 2018, Journal of cellular biochemistry.

Comparative efficacy and safety of lipid-lowering agents in patients with hypercholesterolemia

P. Luo, S. Du, S. Shen, 2019, Medicine.

Impact of Atorvastatin Combined with Ezetimibe for the Treatment of Carotid Atherosclerosis in Patients with Coronary Heart Disease.

P. Luo, S. Du, Haohui Zhu, 2016, Acta Cardiologica Sinica.

LncRNA DYNLRB2-2 inhibits THP-1 macrophage foam cell formation by enhancing autophagy

T. Sun, S. Shen, Jifeng Yan, 2019, Biological chemistry.

Toll-like receptor 2 downregulates the cholesterol efflux by activating the nuclear factor-κB pathway in macrophages and may be a potential therapeutic target for the prevention of atherosclerosis

S. Shen, Yongqiang Li, Lixia Wang, 2017, Experimental and therapeutic medicine.

Effect of cardiac resynchronization therapy on patients with heart failure and narrow QRS complexes: a meta-analysis of five randomized controlled trials

S. Shen, Zonglei Zhao, Lixia Wang, 2015, Journal of Interventional Cardiac Electrophysiology.